Improving the effectiveness of eradication therapy for Helicobacter pylori infection

Background. Butyric acid (butyrate) is a short-chain fatty acid produced by anaerobic bacteria of the species Eubacterium rectale, Eubacterium ramulus, Eubacterium hallii, Roseburia cecicola, Roseburia faecis, Faecalibacterium prausnitzii and Coprococcus faecalis, as well as Fusobacteria, non-pathog...

Full description

Bibliographic Details
Published in:Лечащий Врач
Main Authors: E. A. Ljaljukova, E. N. Chernysheva
Format: Article
Language:Russian
Published: Open Systems Publication 2024-12-01
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/1333
_version_ 1849465506505949184
author E. A. Ljaljukova
E. N. Chernysheva
author_facet E. A. Ljaljukova
E. N. Chernysheva
author_sort E. A. Ljaljukova
collection DOAJ
container_title Лечащий Врач
description Background. Butyric acid (butyrate) is a short-chain fatty acid produced by anaerobic bacteria of the species Eubacterium rectale, Eubacterium ramulus, Eubacterium hallii, Roseburia cecicola, Roseburia faecis, Faecalibacterium prausnitzii and Coprococcus faecalis, as well as Fusobacteria, non-pathogenic Clostridium species, plays a key role in the physiology of the gastrointestinal epithelium. The protective effect of butyrate is realised on the part of gastric and intestinal mucosa by stimulation of anti-inflammatory and antioxidant mechanisms. Being a source of energy, it affects a wide range of cellular functions, exerting cytoprotective effect and maintaining homeostasis within the gastrointestinal tract. Butyric acid maintains the integrity of the mucosal barrier, stimulating the production of protective mucus and antimicrobial proteins, and increases the density of epithelial contacts with each other, as well as has an anti-inflammatory effect. Due to pH regulation (creates a slightly acidic environment) promotes the creation of favourable conditions for the growth of its own beneficial microbiota and unfavourable for opportunistic and pathogenic microbiota. In addition to pleiotropic effects on the human macroorganism, butyric acid and its derivatives have a direct antibacterial effect. Uric acid is able to inhibit the growth of Helicobacter pylori and have a destructive effect on the cell membrane of the microorganism, reducing cytoplasmic pH and accumulating toxic anions to prevent colonisation of Helicobacter pylori, generating hydrogen peroxide and damaging pathogenic proteins, membrane lipids and DNA of the bacterial cell.Conclusion. In Russia, as a source of butyric acid (butyrate), a preparation has been registered which, in addition to butyric acid, contains a second active component – inulin, a soluble dietary fibre, which creates a nutritious environment for the intestinal microbiota, thus stimulating the growth of beneficial bacteria and having a prebiotic effect.
format Article
id doaj-art-be2830f91ece43c2b2b0beab34d2d7d0
institution Directory of Open Access Journals
issn 1560-5175
2687-1181
language Russian
publishDate 2024-12-01
publisher Open Systems Publication
record_format Article
spelling doaj-art-be2830f91ece43c2b2b0beab34d2d7d02025-08-20T03:20:17ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812024-12-01012818510.51793/OS.2024.27.12.0121320Improving the effectiveness of eradication therapy for Helicobacter pylori infectionE. A. Ljaljukova0E. N. Chernysheva1Omsk State Medical University; Maikop State Technological University, Medical Institute MaikopAstrakhan State Medical UniversityBackground. Butyric acid (butyrate) is a short-chain fatty acid produced by anaerobic bacteria of the species Eubacterium rectale, Eubacterium ramulus, Eubacterium hallii, Roseburia cecicola, Roseburia faecis, Faecalibacterium prausnitzii and Coprococcus faecalis, as well as Fusobacteria, non-pathogenic Clostridium species, plays a key role in the physiology of the gastrointestinal epithelium. The protective effect of butyrate is realised on the part of gastric and intestinal mucosa by stimulation of anti-inflammatory and antioxidant mechanisms. Being a source of energy, it affects a wide range of cellular functions, exerting cytoprotective effect and maintaining homeostasis within the gastrointestinal tract. Butyric acid maintains the integrity of the mucosal barrier, stimulating the production of protective mucus and antimicrobial proteins, and increases the density of epithelial contacts with each other, as well as has an anti-inflammatory effect. Due to pH regulation (creates a slightly acidic environment) promotes the creation of favourable conditions for the growth of its own beneficial microbiota and unfavourable for opportunistic and pathogenic microbiota. In addition to pleiotropic effects on the human macroorganism, butyric acid and its derivatives have a direct antibacterial effect. Uric acid is able to inhibit the growth of Helicobacter pylori and have a destructive effect on the cell membrane of the microorganism, reducing cytoplasmic pH and accumulating toxic anions to prevent colonisation of Helicobacter pylori, generating hydrogen peroxide and damaging pathogenic proteins, membrane lipids and DNA of the bacterial cell.Conclusion. In Russia, as a source of butyric acid (butyrate), a preparation has been registered which, in addition to butyric acid, contains a second active component – inulin, a soluble dietary fibre, which creates a nutritious environment for the intestinal microbiota, thus stimulating the growth of beneficial bacteria and having a prebiotic effect.https://journal.lvrach.ru/jour/article/view/1333helicobacter pylori eradicationbutyric acidbutyrateinulinintestinal microbiota
spellingShingle E. A. Ljaljukova
E. N. Chernysheva
Improving the effectiveness of eradication therapy for Helicobacter pylori infection
helicobacter pylori eradication
butyric acid
butyrate
inulin
intestinal microbiota
title Improving the effectiveness of eradication therapy for Helicobacter pylori infection
title_full Improving the effectiveness of eradication therapy for Helicobacter pylori infection
title_fullStr Improving the effectiveness of eradication therapy for Helicobacter pylori infection
title_full_unstemmed Improving the effectiveness of eradication therapy for Helicobacter pylori infection
title_short Improving the effectiveness of eradication therapy for Helicobacter pylori infection
title_sort improving the effectiveness of eradication therapy for helicobacter pylori infection
topic helicobacter pylori eradication
butyric acid
butyrate
inulin
intestinal microbiota
url https://journal.lvrach.ru/jour/article/view/1333
work_keys_str_mv AT ealjaljukova improvingtheeffectivenessoferadicationtherapyforhelicobacterpyloriinfection
AT enchernysheva improvingtheeffectivenessoferadicationtherapyforhelicobacterpyloriinfection